Dividend Increases Week 50, 2021

 

In this article, I will go through the weekly dividend increases and cuts in popular and well-known stocks. (Member of The Dividend Champions or Canadian All-Star list)

 

Recently, 17 companies announced dividend increases. Note that no dividend cuts or suspensions were announced during this period.

 

The table below summarises the dividend change announcements.  The table shows the current dividend, the new dividend and the percentage increase (%). Dividends are shown on an annual basis and in US dollars unless otherwise stated. Yield is the new dividend yield of the most recent price, and Years is the years of consecutive dividend increases.

 

 

Notable Analyst Upgrades and Downgrades for Week of November 1 2021 (Part 1)

 

Upgrades:

 

Intel (NASDAQ:INTC) was upgraded by analysts at Northland Securities from an “underperform” rating to a “market perform” rating in a research note issued on Monday, PriceTargets.com reports. The firm presently has a $49.00 price target on the chip maker’s stock. Northland Securities’ price target indicates a potential downside of 0.39% from the company’s current price.

A number of other equities research analysts also recently commented on INTC. The Goldman Sachs Group restated a “sell” rating and issued a $44.00 target price (down previously from $51.00) on shares of Intel in a research report on Friday, October 22nd. Zacks Investment Research upgraded Intel from a “hold” rating to a “buy” rating and set a $58.00 target price on the stock in a research report on Friday, July 9th. Citigroup reduced their target price on Intel from $57.00 to $52.00 and set a “neutral” rating on the stock in a research report on Friday, October 22nd. Credit Suisse Group set a $80.00 price objective on Intel in a report on Friday, October 22nd. Finally, Bank of America cut their price objective on Intel from $52.00 to $45.00 and set an “underperform” rating on the stock in a report on Friday, October 22nd. Eleven equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $56.52. Read more …

 

Merck & Co., Inc. (NYSE:MRK) was upgraded by equities researchers at Argus from a “hold” rating to a “buy” rating in a note issued to investors on Monday, Analyst Price Targets reports. The brokerage presently has a $110.00 price objective on the stock. Argus’ price objective would suggest a potential upside of 25.40% from the company’s previous close.

Other equities analysts have also recently issued reports about the company. Morgan Stanley lifted their price objective on Merck & Co., Inc. from $88.00 to $90.00 and gave the stock an “equal weight” rating in a report on Friday. Barclays lifted their price objective on Merck & Co., Inc. from $87.00 to $92.00 and gave the stock an “overweight” rating in a report on Friday, October 8th. Truist began coverage on Merck & Co., Inc. in a research report on Tuesday, July 27th. They set a “buy” rating and a $92.00 price target for the company. Berenberg Bank reissued a “hold” rating and set a $92.00 price target (up previously from $86.00) on shares of Merck & Co., Inc. in a research report on Sunday, October 10th. Finally, Zacks Investment Research raised Merck & Co., Inc. from a “sell” rating to a “hold” rating and set a $82.00 price target for the company in a research report on Tuesday, August 24th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Merck & Co., Inc. presently has an average rating of “Buy” and an average target price of $94.16. Read more …

 

Starbucks (NASDAQ:SBUX) was upgraded by research analysts at Stephens from an “equal weight” rating to an “overweight” rating in a research note issued to investors on Monday, The Fly reports. The firm currently has a $130.00 price objective on the coffee company’s stock, up from their previous price objective of $118.00. Stephens’ price objective indicates a potential upside of 22.56% from the stock’s previous close.

A number of other equities research analysts have also weighed in on the stock. Piper Sandler boosted their price objective on shares of Starbucks from $104.00 to $108.00 and gave the stock a “neutral” rating in a report on Wednesday, July 28th. Bank of America assumed coverage on shares of Starbucks in a report on Monday, October 11th. They issued a “buy” rating and a $135.00 price objective for the company. Robert W. Baird lowered their price objective on shares of Starbucks from $144.00 to $128.00 and set an “outperform” rating for the company in a report on Friday. UBS Group lowered their price objective on shares of Starbucks from $125.00 to $115.00 and set a “neutral” rating for the company in a report on Friday. Finally, Atlantic Securities downgraded shares of Starbucks from an “overweight” rating to a “neutral” rating and set a $105.00 target price on the stock. in a research note on Thursday, September 30th. Nine analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $123.00. Read more …

 

 

Sanofi (NASDAQ:SNY) was upgraded by stock analysts at HSBC from a “hold” rating to a “buy” rating in a report released on Monday, The Fly reports.

Several other brokerages have also issued reports on SNY. UBS Group reiterated a “buy” rating on shares of Sanofi in a research note on Thursday, August 12th. Morgan Stanley restated an “overweight” rating on shares of Sanofi in a research note on Friday, August 6th. Zacks Investment Research upgraded shares of Sanofi from a “hold” rating to a “buy” rating and set a $51.00 price objective on the stock in a research note on Wednesday, September 29th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Sanofi in a research note on Thursday, October 14th. Finally, SVB Leerink upgraded shares of Sanofi from a “market perform” rating to an “outperform” rating in a research note on Monday, September 27th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $51.00. Read more …

Most Significant Insider Trades: Week of September 20, 2021

 

Disposals:

 

Halliburton (NYSE:HAL) Director Murry Gerber sold 44,590 shares of the stock in a transaction on Monday, September 20th. The shares were sold at an average price of $19.33, for a total value of $861,924.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Shares of NYSE HAL traded down $0.12 during midday trading on Tuesday, reaching $19.48. 6,125,435 shares of the company’s stock traded hands, compared to its average volume of 9,502,723. The company has a market cap of $17.35 billion, a price-to-earnings ratio of 121.76 and a beta of 2.84. The stock’s 50 day simple moving average is $20.08 and its 200-day simple moving average is $21.54. The company has a quick ratio of 1.75, a current ratio of 2.29 and a debt-to-equity ratio of 1.68. Halliburton has a one year low of $10.60 and a one year high of $25.00. Read more …

 

UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $419.00, for a total value of $1,047,500.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

UNH traded down $0.36 on Tuesday, hitting $412.34. The company had a trading volume of 2,382,123 shares, compared to its average volume of 2,984,847. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62. The firm has a market cap of $388.80 billion, a P/E ratio of 27.24, a PEG ratio of 1.62 and a beta of 0.77. The company’s fifty day moving average price is $416.51 and its 200 day moving average price is $400.62. UnitedHealth Group Incorporated has a 1 year low of $289.64 and a 1 year high of $431.36. Read more …

 

Bristol-Myers Squibb (NYSE:BMY) CEO Giovanni Caforio sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, September 20th. The shares were sold at an average price of $60.64, for a total value of $1,516,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

NYSE BMY traded down $0.18 during midday trading on Wednesday, hitting $60.15. The company had a trading volume of 9,658,651 shares, compared to its average volume of 10,596,237. The company has a market capitalization of $133.66 billion, a PE ratio of -26.57, a P/E/G ratio of 1.20 and a beta of 0.61. The company has a current ratio of 1.54, a quick ratio of 1.42 and a debt-to-equity ratio of 1.15. The firm has a 50-day moving average price of $66.48 and a 200-day moving average price of $65.37. Bristol-Myers Squibb has a twelve month low of $56.75 and a twelve month high of $69.75. Read more …

 

 

Williams-Sonoma, Inc. (NYSE:WSM) insider Ryan Ross sold 2,700 shares of the stock in a transaction that occurred on Tuesday, September 21st. The shares were sold at an average price of $185.57, for a total transaction of $501,039.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Ryan Ross also recently made the following trade(s):

On Wednesday, July 7th, Ryan Ross sold 2,400 shares of Williams-Sonoma stock. The stock was sold at an average price of $165.00, for a total value of $396,000.00.

On Friday, June 25th, Ryan Ross sold 5,600 shares of Williams-Sonoma stock. The stock was sold at an average price of $160.42, for a total value of $898,352.00.

Shares of WSM traded down $1.40 during midday trading on Thursday, reaching $188.51. 534,455 shares of the stock were exchanged, compared to its average volume of 1,203,200. Williams-Sonoma, Inc. has a twelve month low of $85.30 and a twelve month high of $204.41. The company has a market cap of $14.02 billion, a P/E ratio of 15.07, a PEG ratio of 1.15 and a beta of 1.68. The stock’s 50 day simple moving average is $168.25 and its 200 day simple moving average is $167.40. Read more …

Notable Analyst Upgrades and Downgrades for Week of April 26, 2021

 

Upgrades:

 

Simon Property Group (NYSE:SPG) was upgraded by equities research analysts at Evercore ISI from an "in-line" rating to an "outperform" rating in a research report issued to clients and investors on Monday, Briefing.com reports. The firm presently has a $128.00 price objective on the real estate investment trust's stock, up from their previous price objective of $112.00. Evercore ISI's price target indicates a potential upside of 9.48% from the company's previous close.

A number of other research firms also recently commented on SPG. Mizuho increased their price objective on shares of Simon Property Group from $74.00 to $97.00 and gave the company a "neutral" rating in a report on Tuesday, February 9th. Piper Sandler upped their price objective on shares of Simon Property Group from $115.00 to $130.00 and gave the company an "overweight" rating in a report on Thursday, March 11th. Zacks Investment Research raised shares of Simon Property Group from a "sell" rating to a "hold" rating and set a $92.00 target price on the stock in a research note on Monday, January 11th. Morgan Stanley boosted their target price on shares of Simon Property Group from $125.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, April 13th. Finally, BTIG Research raised their price target on shares of Simon Property Group from $99.00 to $125.00 and gave the stock a "buy" rating in a report on Tuesday, February 9th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have assigned a buy rating to the company. Simon Property Group has a consensus rating of "Hold" and a consensus price target of $105.94. Read more …

 

Brookfield Renewable (NYSE:BEPC) was upgraded by research analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research note issued to investors on Monday, The Fly reports. The firm presently has a $53.00 price target on the stock, up from their previous price target of $47.00. Wells Fargo & Company‘s price objective suggests a potential upside of 20.65% from the company’s current price.

Separately, JPMorgan Chase & Co. initiated coverage on shares of Brookfield Renewable in a research note on Wednesday, March 31st. They set a “neutral” rating and a $49.00 target price for the company.

NYSE:BEPC opened at $43.93 on Monday. Brookfield Renewable has a one year low of $26.67 and a one year high of $63.31. The company has a fifty day moving average price of $45.37 and a 200 day moving average price of $57.13. Read more …

 

Weyerhaeuser (NYSE:WY) was upgraded by equities research analysts at Raymond James from an "outperform" rating to a "strong-buy" rating in a report issued on Monday, Price Targets.com reports.

Separately, DA Davidson increased their target price on shares of Weyerhaeuser from $29.00 to $34.00 in a research note on Monday, February 1st. Four investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. Weyerhaeuser currently has a consensus rating of "Buy" and an average price target of $31.38.

NYSE WY traded up $0.61 on Monday, hitting $39.99. The stock had a trading volume of 166,179 shares, compared to its average volume of 4,538,245. Weyerhaeuser has a 52-week low of $16.05 and a 52-week high of $39.88. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.72 and a current ratio of 2.28. The company has a market capitalization of $29.94 billion, a price-to-earnings ratio of 96.05 and a beta of 1.96. The firm has a 50-day moving average of $36.48 and a 200-day moving average of $32.90. Read more …

 

 

ViacomCBS (NASDAQ:VIAC) was upgraded by equities researchers at Citigroup from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, The Fly reports.

Several other equities analysts have also issued reports on VIAC. Evercore ISI boosted their target price on shares of ViacomCBS from $40.00 to $50.00 in a report on Thursday, February 25th. Barrington Research downgraded shares of ViacomCBS from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 25th. Barclays downgraded shares of ViacomCBS from an “overweight” rating to an “underweight” rating and decreased their target price for the stock from $36.00 to $35.00 in a research report on Tuesday, January 19th. Gabelli raised shares of ViacomCBS from a “hold” rating to a “buy” rating in a research report on Tuesday, March 30th. Finally, BMO Capital Markets raised shares of ViacomCBS from an “underperform” rating to a “market perform” rating and set a $70.00 price objective for the company in a research report on Monday, March 29th. Seven equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and seven have issued a buy rating to the stock. ViacomCBS has an average rating of “Hold” and an average price target of $47.25. Read more …

Week's Most Significant Insider Trades: Week of March 22, 2021

 

Disposals:

 

Visa Inc. (NYSE:V) Director Robert W. Matschullat sold 29,956 shares of the firm’s stock in a transaction that occurred on Thursday, March 18th. The stock was sold at an average price of $223.02, for a total transaction of $6,680,787.12. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

V opened at $208.00 on Tuesday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.68. The stock’s 50 day moving average price is $212.23 and its two-hundred day moving average price is $206.40. The firm has a market capitalization of $406.08 billion, a P/E ratio of 42.62, a price-to-earnings-growth ratio of 3.80 and a beta of 0.96. Visa Inc. has a 12-month low of $133.93 and a 12-month high of $228.23.

Visa (NYSE:V) last posted its quarterly earnings data on Thursday, January 28th. The credit-card processor reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.14. Visa had a return on equity of 37.22% and a net margin of 49.74%. The company had revenue of $5.69 billion during the quarter, compared to analysts’ expectations of $5.52 billion. During the same period in the prior year, the business earned $1.46 earnings per share. Visa’s revenue for the quarter was down 6.1% compared to the same quarter last year. As a group, analysts anticipate that Visa Inc. will post 5.45 earnings per share for the current year. Read more …

 

Best Buy Co., Inc. (NYSE:BBY) CEO Corie S. Barry sold 10,855 shares of the stock in a transaction that occurred on Tuesday, March 23rd. The stock was sold at an average price of $119.03, for a total transaction of $1,292,070.65. Following the sale, the chief executive officer now owns 194,516 shares in the company, valued at $23,153,239.48. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

 

Best Buy Co., Inc. (NYSE:BBY) COO Rajendra M. Mohan sold 8,640 shares of the business’s stock in a transaction on Tuesday, March 23rd. The shares were sold at an average price of $119.03, for a total transaction of $1,028,419.20. Following the sale, the chief operating officer now directly owns 147,329 shares of the company’s stock, valued at $17,536,570.87. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Rajendra M. Mohan also recently made the following trade(s):

On Tuesday, March 16th, Rajendra M. Mohan sold 4,261 shares of Best Buy stock. The shares were sold at an average price of $113.88, for a total transaction of $485,242.68.

Shares of Best Buy stock traded up $1.86 on Thursday, hitting $116.18. The company had a trading volume of 2,250,583 shares, compared to its average volume of 2,961,744. The business has a 50-day simple moving average of $112.27 and a 200-day simple moving average of $111.02. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.12 and a quick ratio of 0.55. The company has a market cap of $29.05 billion, a PE ratio of 17.37, a PEG ratio of 1.40 and a beta of 1.52. Best Buy Co., Inc. has a 52 week low of $51.71 and a 52 week high of $124.89. Read more …

 

Costco Wholesale Co. (NASDAQ:COST) VP Roland Michael Vachris sold 4,300 shares of the company’s stock in a transaction on Monday, March 22nd. The shares were sold at an average price of $334.30, for a total value of $1,437,490.00. Following the completion of the transaction, the vice president now owns 15,602 shares of the company’s stock, valued at $5,215,748.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

COST stock traded up $5.85 during mid-day trading on Tuesday, reaching $340.34. The company had a trading volume of 3,604,902 shares, compared to its average volume of 3,088,433. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.98 and a quick ratio of 0.53. The stock has a 50 day simple moving average of $339.90 and a two-hundred day simple moving average of $359.73. The company has a market capitalization of $150.61 billion, a price-to-earnings ratio of 34.94, a PEG ratio of 4.17 and a beta of 0.66. Costco Wholesale Co. has a 52 week low of $279.21 and a 52 week high of $393.15. Read more …

 

 

FedEx Co. (NYSE:FDX) VP John L. Merino sold 10,000 shares of the company's stock in a transaction that occurred on Monday, March 22nd. The stock was sold at an average price of $273.30, for a total value of $2,733,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

NYSE:FDX traded down $7.21 during trading hours on Tuesday, reaching $266.81. 2,268,258 shares of the company's stock were exchanged, compared to its average volume of 2,691,275. The firm has a market capitalization of $70.80 billion, a price-to-earnings ratio of 29.47, a P/E/G ratio of 1.22 and a beta of 1.30. The company has a quick ratio of 1.71, a current ratio of 1.76 and a debt-to-equity ratio of 1.10. FedEx Co. has a 1-year low of $103.40 and a 1-year high of $305.66. The company has a 50-day moving average of $258.53 and a 200 day moving average of $263.05.

FedEx (NYSE:FDX) last posted its quarterly earnings results on Wednesday, March 17th. The shipping service provider reported $3.47 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $3.21 by $0.26. The firm had revenue of $21.51 billion for the quarter, compared to analyst estimates of $19.90 billion. FedEx had a net margin of 3.28% and a return on equity of 18.65%. FedEx's revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.41 earnings per share. Research analysts forecast that FedEx Co. will post 17.24 EPS for the current fiscal year. Read more …

Is Bristol-Myers Squibb Stock A Buy?

 

Bristol-Myers Squibb Co (NYSE:BMY) a large American pharmaceutical giant. Its prescription drug portfolio includes treatments for a wide variety of ailments, including HIV, cancer, diabetes, cardiovascular disease, and psychiatric disorders.

 

It grew through a series of acquisitions over the years to be a prominent drug company, even before the pandemic.

 

You may buy its drugs, but is Bristol-Myers Squibb stock a Buy?

 

Although it has an impressive portfolio, the government’s Operation Warp Speed coronavirus vaccine program overlooked BMY.

 

Its CEO attached the company to OWS through auxiliary programs, but it didn’t receive the billion-dollar research grants its contemporaries did.

 

Still, it took it on the chin and continued pushing to involve itself in the accompanying research and development.

 

Bristol-Myers Squibb Is A Top 100 Company

 

Bristol-Myers Squibb was founded in 1887 and is a component of both the S&P 100 and S&P 500 indices. It was one of the first companies to focus on high-quality drugs with a high level of purity and pushed for many of the regulations we have today.

 

 

Over the years, it grew through a series of mergers and acquisitions of smaller companies involved in therapeutics, biosciences, and other related markets.

 

Today, it’s one of the 100 largest corporations in the United States, with over 30,000 employees. The company has a broad pipeline of pharmaceuticals and biologic products.

 

Continue reading …

 

Notable Analyst Upgrades and Downgrades for Week of December 14, 2020

 

Upgrades:

 

U.S. Bancorp (NYSE:USB) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating in a research report issued to clients and investors on Monday, Briefing.com reports. The brokerage currently has a $51.50 price objective on the financial services provider's stock. JPMorgan Chase & Co.'s price objective would suggest a potential upside of 12.35% from the company's previous close.

Several other analysts have also issued reports on the company. TheStreet raised U.S. Bancorp from a "c" rating to a "b-" rating in a research note on Thursday, October 15th. BidaskClub raised U.S. Bancorp from a "hold" rating to a "buy" rating in a research note on Saturday. Morgan Stanley upgraded U.S. Bancorp from an "underweight" rating to an "equal weight" rating and set a $57.00 price objective for the company in a research report on Monday, November 30th. Stephens upgraded U.S. Bancorp from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $42.00 to $52.00 in a research report on Monday, November 30th. Finally, Bank of America upgraded U.S. Bancorp from an "underperform" rating to a "neutral" rating and boosted their price objective for the company from $39.00 to $41.00 in a research report on Wednesday, October 7th. Eleven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company has a consensus rating of "Buy" and an average target price of $47.13. Read more …

 

The Clorox (NYSE:CLX) was upgraded by equities research analysts at Smith Barney Citigroup from a “neutral” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports. The firm presently has a $249.00 target price on the stock, up from their prior target price of $238.00. Smith Barney Citigroup’s price objective points to a potential upside of 22.62% from the company’s previous close.

Other equities analysts also recently issued reports about the stock. JPMorgan Chase & Co. downgraded shares of The Clorox from an “overweight” rating to a “neutral” rating and set a $235.00 target price for the company. in a report on Friday, October 16th. They noted that the move was a valuation call. ValuEngine downgraded shares of The Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, November 10th. DA Davidson raised their target price on shares of The Clorox from $263.00 to $268.00 and gave the company a “buy” rating in a report on Tuesday, November 3rd. Deutsche Bank Aktiengesellschaft raised their target price on shares of The Clorox from $223.00 to $227.00 and gave the company a “hold” rating in a report on Tuesday, November 3rd. Finally, Wells Fargo & Company began coverage on shares of The Clorox in a report on Monday, December 7th. They set an “overweight” rating and a $250.00 target price for the company. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $220.53. Read more …

 

Welltower (NYSE:WELL) was upgraded by KeyCorp from a “sector weight” rating to an “overweight” rating in a report released on Monday, The Fly reports. The firm currently has a $70.00 price objective on the real estate investment trust’s stock. KeyCorp’s price objective indicates a potential upside of 8.95% from the company’s previous close.

Other analysts have also recently issued research reports about the stock. Wells Fargo & Company cut shares of Welltower from an “overweight” rating to an “equal weight” rating and upped their price objective for the company from $54.00 to $63.50 in a research report on Monday, November 16th. Barclays increased their price target on Welltower from $50.00 to $58.00 and gave the stock an “equal weight” rating in a report on Friday, September 4th. Mizuho cut Welltower from a “buy” rating to a “neutral” rating and lifted their price objective for the company from $51.00 to $57.00 in a report on Friday, October 16th. Berenberg Bank lowered Welltower from a “buy” rating to a “hold” rating in a research report on Wednesday, December 2nd. Finally, Scotiabank downgraded shares of Welltower from a “sector perform” rating to a “sector underperform” rating and dropped their target price for the stock from $59.00 to $57.00 in a report on Thursday, December 3rd. One research analyst has rated the stock with a sell rating, eighteen have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $57.64. Read more …

 

 

American Water Works (NYSE:AWK) was upgraded by stock analysts at Bank of America from an "underperform" rating to a "neutral" rating in a research report issued on Monday, The Fly reports.

Other analysts also recently issued reports about the company. Zacks Investment Research upgraded American Water Works from a "hold" rating to a "buy" rating and set a $169.00 price objective for the company in a report on Monday, November 9th. Janney Montgomery Scott downgraded American Water Works from a "buy" rating to a "neutral" rating in a report on Tuesday, October 13th. Barclays upped their price objective on American Water Works from $138.00 to $173.00 and gave the stock an "equal weight" rating in a report on Wednesday, November 18th. Finally, HSBC upgraded American Water Works from a "hold" rating to a "buy" rating and set a $175.00 price target for the company in a report on Monday, November 9th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company's stock. The stock has a consensus rating of "Hold" and an average price target of $145.92.

Shares of American Water Works stock opened at $148.28 on Monday. American Water Works has a fifty-two week low of $92.00 and a fifty-two week high of $172.56. The firm has a market cap of $26.88 billion, a PE ratio of 40.62, a P/E/G ratio of 4.71 and a beta of 0.18. The business's fifty day moving average is $155.39 and its two-hundred day moving average is $143.68. The company has a quick ratio of 0.85, a current ratio of 0.87 and a debt-to-equity ratio of 1.47. Read more …

 

Week's Most Significant Insider Trades: Week of November 23, 2020

 

Disposals:

 

Duke Energy Co. (NYSE:DUK) COO Dhiaa M. Jamil sold 3,500 shares of the business's stock in a transaction dated Friday, November 20th. The shares were sold at an average price of $92.63, for a total value of $324,205.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Duke Energy stock traded up $0.75 during trading hours on Monday, hitting $93.33. The stock had a trading volume of 3,815,948 shares, compared to its average volume of 3,787,323. The company has a 50-day moving average of $93.03 and a two-hundred day moving average of $85.53. The company has a quick ratio of 0.33, a current ratio of 0.52 and a debt-to-equity ratio of 1.24. The company has a market cap of $68.14 billion, a PE ratio of 33.91, a price-to-earnings-growth ratio of 5.20 and a beta of 0.24. Duke Energy Co. has a fifty-two week low of $62.13 and a fifty-two week high of $103.79

Duke Energy (NYSE:DUK) last posted its quarterly earnings results on Thursday, November 5th. The utilities provider reported $1.87 EPS for the quarter, beating the consensus estimate of $1.79 by $0.08. The firm had revenue of $6.72 billion during the quarter, compared to analysts' expectations of $7.34 billion. Duke Energy had a return on equity of 8.28% and a net margin of 8.68%. The company's revenue for the quarter was down 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.79 EPS. As a group, analysts forecast that Duke Energy Co. will post 5.07 EPS for the current fiscal year. Read more ...

 

The TJX Companies, Inc. (NYSE:TJX) Chairman Carol Meyrowitz sold 77,892 shares of the business's stock in a transaction that occurred on Friday, November 20th. The stock was sold at an average price of $61.22, for a total value of $4,768,548.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

NYSE TJX traded up $1.12 on Monday, reaching $61.80. The company's stock had a trading volume of 8,248,813 shares, compared to its average volume of 8,232,387. The TJX Companies, Inc. has a 52 week low of $32.72 and a 52 week high of $65.14. The company has a current ratio of 1.51, a quick ratio of 1.02 and a debt-to-equity ratio of 1.17. The firm has a market cap of $74.10 billion, a PE ratio of 108.42, a price-to-earnings-growth ratio of 29.72 and a beta of 0.73. The business has a 50-day moving average price of $56.90 and a 200 day moving average price of $54.14.

The TJX Companies (NYSE:TJX) last released its quarterly earnings data on Tuesday, November 17th. The apparel and home fashions retailer reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.31. The TJX Companies had a return on equity of 13.62% and a net margin of 2.11%. During the same quarter in the prior year, the business earned $0.68 EPS. Analysts anticipate that The TJX Companies, Inc. will post 0.18 earnings per share for the current fiscal year. Read more ...

 

JPMorgan Chase & Co. (NYSE:JPM) EVP Marianne Lake sold 15,808 shares of JPMorgan Chase & Co. stock in a transaction that occurred on Tuesday, November 24th. The shares were sold at an average price of $120.01, for a total transaction of $1,897,118.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

JPM stock traded up $5.45 during midday trading on Tuesday, reaching $123.32. The stock had a trading volume of 18,847,579 shares, compared to its average volume of 19,997,709. The firm has a fifty day simple moving average of $105.22 and a two-hundred day simple moving average of $99.51. JPMorgan Chase & Co. has a 52-week low of $76.91 and a 52-week high of $141.10. The company has a debt-to-equity ratio of 1.16, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a market cap of $375.90 billion, a PE ratio of 16.12, a P/E/G ratio of 2.68 and a beta of 1.15.

JPMorgan Chase & Co. (NYSE:JPM) last announced its quarterly earnings data on Monday, October 19th. The financial services provider reported $2.92 earnings per share for the quarter, beating analysts' consensus estimates of $2.23 by $0.69. JPMorgan Chase & Co. had a return on equity of 10.85% and a net margin of 19.16%. The business had revenue of $29.90 billion for the quarter, compared to analyst estimates of $28.20 billion. During the same period in the prior year, the company earned $2.68 earnings per share. The company's revenue was up 4.0% on a year-over-year basis. On average, sell-side analysts predict that JPMorgan Chase & Co. will post 7.47 EPS for the current fiscal year. Read more …

 

 

Bristol-Myers Squibb (NYSE:BMY) EVP Rupert Vessey sold 13,421 shares of Bristol-Myers Squibb stock in a transaction on Monday, November 23rd. The stock was sold at an average price of $61.34, for a total transaction of $823,244.14. Following the sale, the executive vice president now owns 37,922 shares in the company, valued at $2,326,135.48. The sale was disclosed in a document filed with the SEC, which is available through this link.

BMY stock traded down $0.38 on Wednesday, hitting $62.84. 9,403,982 shares of the company were exchanged, compared to its average volume of 13,536,446. Bristol-Myers Squibb has a twelve month low of $45.76 and a twelve month high of $68.34. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.67 and a quick ratio of 1.58. The business’s fifty day moving average is $69.96 and its two-hundred day moving average is $80.55. The stock has a market capitalization of $143.05 billion, a price-to-earnings ratio of -574.68, a price-to-earnings-growth ratio of 1.07 and a beta of 0.67. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of November 16, 2020

 

Upgrades:

 

Bristol-Myers Squibb (NYSE:BMY) - Equities research analysts at William Blair cut their Q2 2021 earnings per share estimates for Bristol-Myers Squibb in a report released on Monday, November 16th. William Blair analyst M. Phipps now expects that the biopharmaceutical company will post earnings of $1.86 per share for the quarter, down from their prior estimate of $1.87.

Several other equities analysts also recently weighed in on the company. Sanford C. Bernstein reiterated a "market perform" rating and set a $72.00 target price on shares of Bristol-Myers Squibb in a research report on Tuesday, November 10th. Societe Generale upgraded Bristol-Myers Squibb from a "hold" rating to a "buy" rating and set a $76.00 target price on the stock in a research report on Monday. Raymond James reiterated a "buy" rating on shares of Bristol-Myers Squibb in a research report on Friday, September 25th. Cfra reiterated a "buy" rating and set a $70.00 target price on shares of Bristol-Myers Squibb in a research report on Sunday, July 26th. Finally, Morgan Stanley increased their target price on Bristol-Myers Squibb from $64.00 to $66.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 12th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. Bristol-Myers Squibb has an average rating of "Buy" and a consensus target price of $73.69. Read more …

 

International Paper (NYSE:IP) was upgraded by research analysts at Smith Barney Citigroup from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Monday, The Fly reports.

Other analysts have also recently issued reports about the company. Argus cut International Paper from a “buy” rating to a “hold” rating in a report on Friday, August 21st. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised International Paper from a “neutral” rating to a “buy” rating in a report on Monday. BMO Capital Markets raised International Paper from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $40.00 to $53.00 in a report on Monday, October 12th. DA Davidson reaffirmed a “buy” rating on shares of International Paper in a report on Friday, July 31st. Finally, Morgan Stanley lifted their price objective on International Paper from $29.00 to $37.00 and gave the company an “underweight” rating in a report on Monday, October 26th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $45.42. Read more …

 

Chevron (NYSE:CVX)‘s stock had its “sector perform” rating reissued by research analysts at Royal Bank of Canada in a note issued to investors on Tuesday, Analyst Ratings Network reports. They currently have a $95.00 price target on the oil and gas company’s stock. Royal Bank of Canada’s price objective suggests a potential upside of 6.79% from the company’s previous close.

Other research analysts have also recently issued reports about the company. Piper Sandler cut Chevron from an “overweight” rating to a “neutral” rating and set a $108.00 target price for the company. in a research note on Monday, August 17th. Morgan Stanley decreased their price objective on Chevron from $108.00 to $105.00 and set an “overweight” rating for the company in a research report on Monday, October 19th. Scotia Howard Weill downgraded shares of Chevron from a “buy” rating to a “sector perform” rating and set a $121.00 target price on the stock. in a report on Thursday, September 24th. Credit Suisse Group reiterated an “outperform” rating and issued a $97.00 price target on shares of Chevron in a report on Tuesday, October 20th. Finally, Raymond James reiterated a “buy” rating on shares of Chevron in a report on Friday, October 30th. Eleven investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $107.28. Read more …

 

The Charles Schwab (NYSE:SCHW) was upgraded by analysts at Smith Barney Citigroup from a "neutral" rating to a "buy" rating in a note issued to investors on Tuesday, The Fly reports. The firm presently has a $54.00 price objective on the financial services provider's stock, up from their prior price objective of $44.00. Smith Barney Citigroup's target price would suggest a potential upside of 10.84% from the stock's previous close.

A number of other research firms have also commented on SCHW. Bank of America upped their price objective on shares of The Charles Schwab from $40.00 to $42.00 and gave the company a "neutral" rating in a research note on Friday, October 16th. Argus upped their price objective on shares of The Charles Schwab from $42.00 to $50.00 in a research note on Friday, October 16th. TheStreet raised shares of The Charles Schwab from a "c" rating to a "b-" rating in a research note on Thursday, October 8th. Deutsche Bank Aktiengesellschaft raised shares of The Charles Schwab from a "hold" rating to a "buy" rating and upped their price objective for the company from $43.00 to $53.00 in a research note on Wednesday, November 11th. Finally, Morgan Stanley upped their price objective on shares of The Charles Schwab from $51.00 to $65.00 and gave the company an "overweight" rating in a research note on Tuesday. Ten research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. The company has a consensus rating of "Hold" and an average target price of $46.75. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of October 19, 2020

 

Upgrades:

 

Franklin Resources (NYSE:BEN) was upgraded by analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a report issued on Monday, Briefing.com reports. The firm presently has a $28.00 target price on the closed-end fund’s stock, up from their previous target price of $24.00. Keefe, Bruyette & Woods’ price target points to a potential upside of 19.20% from the company’s current price.

Other equities research analysts also recently issued research reports about the stock. Credit Suisse Group reaffirmed a “sell” rating and set a $20.00 price target on shares of Franklin Resources in a research note on Friday, September 11th. Zacks Investment Research downgraded shares of Franklin Resources from a “strong-buy” rating to a “hold” rating and set a $22.00 price target on the stock. in a research note on Wednesday, August 5th. Citigroup upped their price target on shares of Franklin Resources from $20.00 to $22.75 and gave the company a “neutral” rating in a research note on Thursday, July 30th. Morgan Stanley started coverage on shares of Franklin Resources in a research note on Thursday, September 3rd. They set an “underweight” rating and a $20.00 price target on the stock. Finally, Barclays reissued a “sell” rating and issued a $19.00 target price on shares of Franklin Resources in a research note on Friday, July 17th. Six analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $22.67. Read more …

 

Kansas City Southern (NYSE:KSU) was upgraded by BMO Capital Markets from a “market perform” rating to an “outperform” rating in a report issued on Monday, Anlyst Ratings reports. The firm presently has a $205.00 price target on the transportation company’s stock, up from their previous price target of $200.00. BMO Capital Markets’ price objective would suggest a potential upside of 14.52% from the company’s current price.

KSU has been the topic of a number of other reports. Stifel Nicolaus cut Kansas City Southern from a “buy” rating to a “hold” rating and set a $162.00 price target on the stock. in a research report on Wednesday, August 5th. Bank of America increased their target price on Kansas City Southern from $203.00 to $205.00 and gave the stock a “buy” rating in a research note on Thursday, September 10th. Morgan Stanley upped their price target on shares of Kansas City Southern from $136.00 to $138.00 and gave the stock an “equal weight” rating in a research note on Monday, October 5th. Credit Suisse Group restated a “buy” rating on shares of Kansas City Southern in a research note on Friday, August 7th. Finally, Barclays upped their target price on shares of Kansas City Southern from $150.00 to $175.00 in a research note on Monday, September 14th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Kansas City Southern presently has an average rating of “Hold” and an average target price of $171.40. Read more …

 

Archer Daniels Midland (NYSE:ADM) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research report issued on Monday, Anlyst Ratings reports. The firm presently has a $60.00 price target on the stock. JPMorgan Chase & Co.'s price objective points to a potential upside of 20.51% from the company's previous close.

A number of other equities research analysts have also recently commented on ADM. Stifel Nicolaus reduced their target price on shares of Archer Daniels Midland from $48.00 to $47.00 and set a "buy" rating for the company in a research report on Tuesday, June 30th. Credit Suisse Group cut shares of Archer Daniels Midland from a "neutral" rating to an "underperform" rating and reduced their target price for the company from $40.00 to $39.00 in a research report on Monday, July 27th. Stephens started coverage on shares of Archer Daniels Midland in a research report on Thursday, July 9th. They issued a "buy" rating and a $52.00 target price for the company. Morgan Stanley increased their target price on shares of Archer Daniels Midland from $40.00 to $45.00 and gave the company an "equal weight" rating in a research report on Monday, August 10th. Finally, Seaport Global Securities started coverage on shares of Archer Daniels Midland in a research report on Tuesday, July 28th. They issued a "buy" rating and a $51.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company's stock. The company presently has an average rating of "Hold" and an average target price of $46.20. Read more …

 

 

Bristol-Myers Squibb (NYSE:BMY) was upgraded by analysts at Guggenheim from a “neutral” rating to a “buy” rating in a research report issued on Monday, Briefing.com reports. The firm currently has a $70.00 price target on the biopharmaceutical company’s stock. Guggenheim’s target price would indicate a potential upside of 14.30% from the company’s previous close.

A number of other research firms have also issued reports on BMY. Cfra restated a “buy” rating and set a $70.00 price objective on shares of Bristol-Myers Squibb in a research report on Sunday, July 26th. Berenberg Bank started coverage on Bristol-Myers Squibb in a research note on Tuesday, September 29th. They set a “buy” rating and a $73.00 target price on the stock. Seaport Global Securities started coverage on Bristol-Myers Squibb in a research note on Tuesday, July 28th. They set an “outperform” rating and a $75.00 target price on the stock. Raymond James reaffirmed a “buy” rating on shares of Bristol-Myers Squibb in a research note on Friday, September 25th. Finally, Morgan Stanley lifted their target price on Bristol-Myers Squibb from $64.00 to $66.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $70.94. Read more …

 

Week's Most Significant Insider Trades: Week of May 25, 2020

Disposals:

Best Buy Co Inc (NYSE:BBY) CEO Corie S. Barry sold 18,844 shares of the firm’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $77.49, for a total value of $1,460,221.56. Following the completion of the transaction, the chief executive officer now owns 163,324 shares of the company’s stock, valued at approximately $12,655,976.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Corie S. Barry also recently made the following trade(s):

On Wednesday, April 15th, Corie S. Barry sold 19 shares of Best Buy stock. The stock was sold at an average price of $67.08, for a total value of $1,274.52.

Read more …

Best Buy Co Inc (NYSE:BBY) COO Rajendra M. Mohan sold 28,263 shares of Best Buy stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $77.49, for a total value of $2,190,099.87. Following the transaction, the chief operating officer now owns 170,413 shares in the company, valued at $13,205,303.37. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Rajendra M. Mohan also recently made the following trade(s):

On Wednesday, April 15th, Rajendra M. Mohan sold 22 shares of Best Buy stock. The stock was sold at an average price of $67.08, for a total value of $1,475.76.

BBY opened at $79.08 on Thursday. The stock has a market cap of $19.81 billion, a price-to-earnings ratio of 14.54, a PEG ratio of 2.25 and a beta of 1.50. Best Buy Co Inc has a 1 year low of $48.10 and a 1 year high of $91.99. The company has a current ratio of 1.02, a quick ratio of 0.57 and a debt-to-equity ratio of 0.79. The stock has a fifty day moving average price of $73.36 and a 200 day moving average price of $77.96. Read more…

Bristol-Myers Squibb Co (NYSE:BMY) SVP Adam Dubow sold 3,200 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $61.01, for a total transaction of $195,232.00. Following the sale, the senior vice president now owns 16,086 shares in the company, valued at approximately $981,406.86. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Shares of NYSE:BMY opened at $60.40 on Thursday. Bristol-Myers Squibb Co has a fifty-two week low of $42.48 and a fifty-two week high of $68.34. The business has a 50-day simple moving average of $61.01 and a two-hundred day simple moving average of $60.80. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.51 and a current ratio of 1.66. The firm has a market cap of $136.49 billion, a price-to-earnings ratio of 11.40, a price-to-earnings-growth ratio of 1.17 and a beta of 0.74. Read more …

Duke Energy Corp (NYSE:DUK) SVP Dwight L. Jacobs sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $84.11, for a total value of $126,165.00. Following the completion of the sale, the senior vice president now directly owns 5,191 shares in the company, valued at $436,615.01. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

NYSE DUK opened at $85.83 on Friday. The stock’s fifty day moving average is $84.76 and its two-hundred day moving average is $89.06. The firm has a market capitalization of $61.45 billion, a P/E ratio of 16.88, a price-to-earnings-growth ratio of 3.48 and a beta of 0.33. The company has a debt-to-equity ratio of 1.25, a quick ratio of 0.45 and a current ratio of 0.67. Duke Energy Corp has a fifty-two week low of $62.13 and a fifty-two week high of $103.79. Read more …

Mastercard Inc (NYSE:MA) Director Steven J. Freiberg sold 4,230 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $303.98, for a total transaction of $1,285,835.40. Following the completion of the transaction, the director now owns 5,376 shares in the company, valued at approximately $1,634,196.48. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of NYSE MA opened at $302.30 on Friday. Mastercard Inc has a fifty-two week low of $199.99 and a fifty-two week high of $347.25. The company has a debt-to-equity ratio of 2.30, a quick ratio of 1.87 and a current ratio of 1.87. The company has a market cap of $304.46 billion, a price-to-earnings ratio of 38.66, a PEG ratio of 3.44 and a beta of 1.06. The business’s 50 day moving average price is $273.34 and its 200-day moving average price is $288.30. Read more …